Literature DB >> 24931228

Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial.

Yi Jiang1, Hui Du1, Jian Liu1, Yixin Zhou2.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) is an important complication after major orthopedic surgery. Pharmaceutical methods represent the main strategy of VTE prevention. The use of aspirin in VTE prevention is still controversial worldwide, especially in China. The purpose of this study was to evaluate the role of aspirin combined with mechanical measures in the prevention of VTE after total knee arthroplasty (TKA).
METHODS: Between January 2012 and May 2013 and in accordance with the inclusion criteria, 120 patients undergoing TKA were randomly allocated to two groups. To prevent VTE, patients in group A received aspirin combined with mechanical measures postoperatively, while patients in group B received low-molecular-weight heparin (LMWH) sodium and rivaroxaban sequentially in combination with mechanical measures postoperatively. All surgeries were performed by one surgeon using a posterior-stabilized cemented prosthesis. The two groups were followed up and compared for the incidence of deep vein thrombosis (DVT) by duplex ultrasound scan and clinical VTE events. The adverse events, the blood loss index, and the cost of VTE prevention were also compared.
RESULTS: DVT was detected in 10 of 60 patients in group A (16.7%, 95% CI: 7.3%-26.1%) compared with 11 of 60 in group B (18.3%, 95% CI: 8.5%-27.8%) (P = 0.500). There is no statistical evidence supporting the inferior effect of aspirin in preventing DVT as compared with the other medications. There were no cases of symptomatic VTE or death during the follow-up period. Area of ecchymosis was lower in group A than in group B, and the differences were statistically significant. Patients in group A had the lower blood loss index as compared with patients in group B. No transfusion cases were found in both groups. The differences were statistically significant. The cost of VTE prevention analysis indicated a cost reduction using aspirin in group A compared with using LMWH and rivaroxaban in group B.
CONCLUSION: Aspirin combined with mechanical measures had a good effect on prevention of VTE after TKA and resulted in lower cost, less blood loss, and less subcutaneous ecchymosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24931228

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

1.  Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?

Authors:  Abiram Bala; James I Huddleston; Stuart B Goodman; William J Maloney; Derek F Amanatullah
Journal:  Clin Orthop Relat Res       Date:  2017-05-31       Impact factor: 4.176

2.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.

Authors:  I Azboy; R Barrack; A M Thomas; F S Haddad; J Parvizi
Journal:  Bone Joint J       Date:  2017-11       Impact factor: 5.082

Review 4.  A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years.

Authors:  Dylan A Mistry; Amit Chandratreya; Paul Y F Lee
Journal:  Surg J (N Y)       Date:  2017-12-29

5.  Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.

Authors:  Jichao Liu; Jinlong Zhao; Yong Yan; Jinping Su
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 6.  Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis.

Authors:  Bangsheng Hu; Lianxiang Jiang; Haixia Tang; Meizhu Hu; Jun Yu; Zeping Dai
Journal:  J Orthop Surg Res       Date:  2021-02-13       Impact factor: 2.359

Review 7.  New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism.

Authors:  Ymer H Mekaj; Fetije T Daci; Agon Y Mekaj
Journal:  Ther Clin Risk Manag       Date:  2015-09-24       Impact factor: 2.423

8.  Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: A protocol for meta-analysis.

Authors:  Guoping Le; Chengzhi Yang; Ming Zhang; Licheng Xi; Hanwen Luo; Jingli Tang; Jinmin Zhao
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

9.  Efficacy and risks of fondaparinux 7.5 mg for deep vein thrombosis after total knee arthroplasty.

Authors:  Sho Nojiri; Kazue Hayakawa; Hideki Date; Harumoto Yamada
Journal:  Fujita Med J       Date:  2018-12-06

Review 10.  New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis.

Authors:  Yi-Hu Yi; Song Gong; Tian-Lun Gong; Ling-Yun Zhou; Can Hu; Wei-Hua Xu
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.